Lysosomal dysfunction causes microglia-specific epigenetic and transcriptional changes linked to neurodegenerative diseases, with a significant impact observed in Sgsh-deficient mice.
- 1 cited this week
Moving in Immunity, eLife, Nature Genetics and Neuron.
Rebuilt
Lysosomal dysfunction causes microglia-specific epigenetic and transcriptional changes linked to neurodegenerative diseases, with a significant impact observed in Sgsh-deficient mice.
Progranulin deficiency causes lysosomal dysfunction that triggers maladaptive myeloid cell states via MITF/TFE transcription factors, impacting neurodegeneration.
Deletion of SPI1 in microglia worsens amyloid pathology by reducing microglial response and phagocytosis in Alzheimer's disease models.
A disease-associated microglial subtype with elevated GPNMB expands with Alzheimer's pathology and depends on TREM2 for neuroprotection.
Sibling-derived microglia comprise up to 52% of microglial cells in marmoset brains, highlighting extensive hematopoietic chimerism within neural tissue.
Newest first · last 60 days
Microglia in human forebrain organoids mediate amyloid-β clearance, recruit CD8+ T cells via CCL4/5 signaling, and establish a neuroinflammatory feedback loop in Alzheimer’s disease models.
A non-canonical reactive astrocyte state (Ast10) is linked to neuropathologies and cognitive decline in Alzheimer's disease across diverse human brains.
Amyloid clearance after aducanumab treatment is linked to reduced tau pathology and slower cortical atrophy in Alzheimer disease.
Early infiltration of ischemia-conditioned Tregs at day 5 post-MCAO reduces BBB damage by suppressing neutrophil extracellular traps in ischemic stroke.
Maternal type I interferon signaling causes TREM2 dysregulation and synaptic dysfunction in offspring hippocampus in a neurodevelopmental disorder model.
Oligodendrocytes actively support CNS function through metabolic provision, adaptive myelination, and repair, but become dysfunctional in aging and disease.
AI-based framework identifies approximately 1.5 million phenotype-associated cells from over 1,000 brains with Alzheimer's disease phenotypes, revealing key cell subpopulations and pathways.
A human iPSC-derived spheroid model reveals that remyelinated axons have thinner myelin sheaths after injury, advancing understanding of human myelin repair mechanisms.
Wild type bone marrow-derived microglia-like cells prevent strain-dependent thalamic calcification in Csf1r mutant mice.
PLA2G2D in tumour-draining lymph nodes acts as a novel immune checkpoint that suppresses anti-tumour T cell responses, with inhibition reducing tumour growth in melanoma models.
TRAM enables receptor-free myddosome formation, sustaining hours-long NF-κB activation and inflammatory gene expression in TLR signaling.
Exogenous CoA acts as a weak TLR4 agonist that enhances IL-4 driven macrophage activation via MyD88 in vitro and in vivo.
Journals this month
Topics moving, week to 22 Oct 2026